Federal Register / Vol. 85, No. 229 / Friday, November 27, 2020 / Notices 76105 

Commission’s rules; any submissions 

that contain BPI must also conform with 

the requirements of §§ 201.6, 207.3, and 

207.7 of the Commission’s rules. The 

Commission’s Handbook on Filing 

Procedures, available on the 

Commission’s website at https:// 

www.usitc.gov/documents/handbook_

on_filing_procedures.pdf, elaborates 

upon the Commission’s procedures with 

respect to filings. 

Additional written submissions to the 

Commission, including requests 

pursuant to § 201.12 of the 

Commission’s rules, shall not be 

accepted unless good cause is shown for 

accepting such submissions, or unless 

the submission is pursuant to a specific 

request by a Commissioner or 

Commission staff. 

In accordance with §§ 201.16(c) and 

207.3 of the Commission’s rules, each 

document filed by a party to the 

investigations must be served on all 

other parties to the investigations (as 

identified by either the public or BPI 

service list), and a certificate of service 

must be timely filed. The Secretary will 

not accept a document for filing without 

a certificate of service. 

Authority: These investigations are being 

conducted under authority of title VII of the 

Tariff Act of 1930; this notice is published 

pursuant to § 207.21 of the Commission’s 

rules. 

By order of the Commission. 

Issued: November 20, 2020. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2020–26147 Filed 11–25–20; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation Nos. 701–TA–645 and 731– 

TA–1495–1501 (Final)] 

Mattresses From Cambodia, China, 

Indonesia, Malaysia, Serbia, Thailand, 

Turkey, and Vietnam; Scheduling of 

the Final Phase of Countervailing Duty 

and Antidumping Duty Investigations 

AGENCY: United States International 

Trade Commission. 

ACTION: Notice. 

SUMMARY: The Commission hereby gives 

notice of the scheduling of the final 

phase of antidumping and 

countervailing duty investigation Nos. 

701–TA–645 and 731–TA–1495–1501 

(Final) pursuant to the Tariff Act of 

1930 (‘‘the Act’’) to determine whether 

an industry in the United States is 

materially injured or threatened with 

material injury, or the establishment of 

an industry in the United States is 

materially retarded, by reason of 

imports of mattresses from Cambodia, 

Indonesia, Malaysia, Serbia, Thailand, 

Turkey, and Vietnam, provided for in 

subheadings 9404.21.00, 9404.29.10, 

9404.29.90, 9401.40.00, and 9401.90.50 

of the Harmonized Tariff Schedule of 

the United States, preliminarily 

determined by the Department of 

Commerce (‘‘Commerce’’) to be sold in 

the United States at less than fair value 

and imports of mattresses from China 

preliminarily determined by Commerce 

to be subsidized by the Government of 

China. 

DATES: November 3, 2020. 

FOR FURTHER INFORMATION CONTACT: 

Mary Messer ((202) 205–3193), Office of 

Investigations, U.S. International Trade 

Commission, 500 E Street SW, 

Washington, DC 20436. Hearingimpaired persons can obtain 

information on this matter by contacting 

the Commission’s TDD terminal on 202– 

205–1810. Persons with mobility 

impairments who will need special 

assistance in gaining access to the 

Commission should contact the Office 

of the Secretary at 202–205–2000. 

General information concerning the 

Commission may also be obtained by 

accessing its internet server (https://

www.usitc.gov). The public record for 

these investigations may be viewed on 

the Commission’s electronic docket 

(EDIS) at https://edis.usitc.gov. 

SUPPLEMENTARY INFORMATION: 

Scope.—For purposes of these 

investigations, Commerce has defined 

the subject merchandise as follows: 

‘‘. . . all types of youth and adult 

mattresses. The term ‘‘mattress’’ denotes 

an assembly of materials that at a 

minimum includes a ‘‘core,’’ which 

provides the main support system of the 

mattress, and may consist of 

innersprings, foam, other resilient 

filling, or a combination of these 

materials. Mattresses may also contain: 

(1) ‘‘Upholstery,’’ the material between 

the core and the top panel of the ticking 

on a single-sided mattress; or between 

the core and the top and bottom panel 

of the ticking on a double-sided 

mattress; and/or (2) ‘‘ticking,’’ the 

outermost layer of fabric or other 

material (e.g., vinyl) that encloses the 

core and any upholstery, also known as 

a cover. 

The scope of this investigation is 

restricted to only ‘‘adult mattresses’’ and 

‘‘youth mattresses.’’ ‘‘Adult mattresses’’ 

are frequently described as ‘‘twin,’’ 

‘‘extra-long twin,’’ ‘‘full,’’ ‘‘queen,’’ 

‘‘king,’’ or ‘‘California king’’ mattresses. 

‘‘Youth mattresses’’ are typically 

described as ‘‘crib,’’ ‘‘toddler,’’ or 

‘‘youth’’ mattresses. All adult and youth 

mattresses are included regardless of 

size and size description. 

The scope encompasses all types of 

‘‘innerspring mattresses,’’ ‘‘noninnerspring mattresses,’’ and ‘‘hybrid 

mattresses.’’ ‘‘Innerspring mattresses’’ 

contain innersprings, a series of metal 

springs joined together in sizes that 

correspond to the dimensions of 

mattresses. Mattresses that contain 

innersprings are referred to as 

‘‘innerspring mattresses’’ or ‘‘hybrid 

mattresses.’’ ‘‘Hybrid mattresses’’ 

contain two or more support systems as 

the core, such as layers of both memory 

foam and innerspring units. 

‘‘Non-innerspring mattresses’’ are 

those that do not contain any 

innerspring units. They are generally 

produced from foams (e.g., 

polyurethane, memory (viscoelastic), 

latex foam, gel- infused viscoelastic (gel 

foam), thermobonded polyester, 

polyethylene) or other resilient filling. 

Mattresses covered by the scope of 

this investigation may be imported 

independently, as part of furniture or 

furniture mechanisms (e.g., convertible 

sofa bed mattresses, sofa bed mattresses 

imported with sofa bed mechanisms, 

corner group mattresses, day-bed 

mattresses, roll-away bed mattresses, 

high risers, trundle bed mattresses, crib 

mattresses), or as part of a set in 

combination with a ‘‘mattress 

foundation.’’ ‘‘Mattress foundations’’ are 

any base or support for a mattress. 

Mattress foundations are commonly 

referred to as ‘‘foundations,’’ 

‘‘boxsprings,’’ ‘‘platforms,’’ and/or 

‘‘bases.’’ Bases can be static, foldable, or 

adjustable. Only the mattress is covered 

by the scope if imported as part of 

furniture, with furniture mechanisms, or 

as part of a set in combination with a 

mattress foundation. 

Excluded from the scope of this 

investigation are ‘‘futon’’ mattresses. A 

‘‘futon’’ is a bi-fold frame made of wood, 

metal, or plastic material, or any 

combination thereof, that functions as 

both seating furniture (such as a couch, 

love seat, or sofa) and a bed. A ‘‘futon 

mattress’’ is a tufted mattress, where the 

top covering is secured to the bottom 

with thread that goes completely 

through the mattress from the top 

through to the bottom, and it does not 

contain innersprings or foam. A futon 

mattress is both the bed and seating 

surface for the futon. 

Also excluded from the scope are 

airbeds (including inflatable mattresses) 

and waterbeds, which consist of air- or 

liquid-filled bladders as the core or 

main support system of the mattress. 

Also excluded is certain 

multifunctional furniture that is 


jbell on DSKJLSW7X2PROD with NOTICES
76106 Federal Register / Vol. 85, No. 229 / Friday, November 27, 2020 / Notices 

convertible from seating to sleeping, 

regardless of filler material or 

components, where that filler material 

or components are upholstered, 

integrated into the design and 

construction of, and inseparable from, 

the furniture framing, and the outermost 

layer of the multifunctional furniture 

converts into the sleeping surface. Such 

furniture may, and without limitation, 

be commonly referred to as ‘‘convertible 

sofas,’’ ‘‘sofabeds,’’ ‘‘sofa chaise 

sleepers,’’ ‘‘futons,’’ ‘‘ottoman sleepers’’ 

or a like description. 

Also excluded from the scope of this 

investigation are any products covered 

by the existing antidumping duty orders 

on uncovered innerspring units from 

China or Vietnam. See Uncovered 

Innerspring Units from the People’s 

Republic of China: Notice of 

Antidumping Duty Order, 74 FR 7661 

(February 19, 2009); Uncovered 

Innerspring Units from the Socialist 

Republic of Vietnam, 73 FR 75391 

(December 11, 2008). 

Also excluded from the scope of this 

investigation are bassinet pads with a 

nominal length of less than 39 inches, 

a nominal width less than 25 inches, 

and a nominal depth of less than 2 

inches. 

Additionally, also excluded from the 

scope of this investigation are ‘‘mattress 

toppers.’’ A ‘‘mattress topper’’ is a 

removable bedding accessory that 

supplements a mattress by providing an 

additional layer that is placed on top of 

a mattress. Excluded mattress toppers 

have a height of four inches or less. 

The products subject to this 

investigation are currently . . . 

classifiable under HTSUS subheadings: 

9404.21.0010, 9404.21.0013, 

9404.29.1005, 9404.29.1013, 

9404.29.9085, and 9404.29.9087. 

Products subject to this investigation 

may also enter under HTSUS 

subheadings: 9404.21.0095, 

9404.29.1095, 9404.29.9095, 

9401.40.0000, and 9401.90.5081. 

Although the HTSUS subheadings are 

provided for convenience and customs 

purposes, the written description of the 

merchandise subject to this 

investigation is dispositive.’’ 

Background.—The final phase of 

these investigations is being scheduled 

pursuant to sections 705(b) and 731(b) 

of the Tariff Act of 1930 (19 U.S.C. 

1671d(b) and 1673d(b)), as a result of 

affirmative preliminary determinations 

by Commerce that certain benefits 

which constitute subsidies within the 

meaning of § 703 of the Act (19 U.S.C. 

1671b) are being provided to 

manufacturers, producers, or exporters 

in China of mattresses, and that such 

products imported from Cambodia, 

Indonesia, Malaysia, Serbia, Thailand, 

Turkey, and Vietnam are being sold in 

the United States at less than fair value 

within the meaning of § 733 of the Act 

(19 U.S.C. 1673b). The investigations 

were requested in petitions filed on 

March 31, 2020, by Brooklyn Bedding 

(Phoenix, Arizona), Corsicana Mattress 

Company (Dallas, Texas), Elite Comfort 

Solutions (Newnan, Georgia), FXI, Inc. 

(Media, Pennsylvania), Innocor, Inc. 

(Media, Pennsylvania), Kolcraft 

Enterprises, Inc. (Chicago, Illinois), 

Leggett & Platt, Incorporated (Carthage, 

Missouri), the International Brotherhood 

of Teamsters (Washington, DC), and 

United Steel, Paper and Forestry, 

Rubber, Manufacturing, Energy, Allied 

Industrial and Service Workers 

International Union, AFL–CIO 

(Washington, DC). 

For further information concerning 

the conduct of this phase of the 

investigations, hearing procedures, and 

rules of general application, consult the 

Commission’s Rules of Practice and 

Procedure, part 201, subparts A and B 

(19 CFR part 201), and part 207, 

subparts A and C (19 CFR part 207). 

Participation in the investigations and 

public service list.—Persons, including 

industrial users of the subject 

merchandise and, if the merchandise is 

sold at the retail level, representative 

consumer organizations, wishing to 

participate in the final phase of these 

investigations as parties must file an 

entry of appearance with the Secretary 

to the Commission, as provided in 

§ 201.11 of the Commission’s rules, no 

later than 21 days prior to the hearing 

date specified in this notice. A party 

that filed a notice of appearance during 

the preliminary phase of the 

investigations need not file an 

additional notice of appearance during 

this final phase. The Secretary will 

maintain a public service list containing 

the names and addresses of all persons, 

or their representatives, who are parties 

to the investigations. 

Please note the Secretary’s Office will 

accept only electronic filings during this 

time. Filings must be made through the 

Commission’s Electronic Document 

Information System (EDIS, https:// 

edis.usitc.gov.) No in-person paperbased filings or paper copies of any 

electronic filings will be accepted until 

further notice. 

Limited disclosure of business 

proprietary information (BPI) under an 

administrative protective order (APO) 

and BPI service list.—Pursuant to 

§ 207.7(a) of the Commission’s rules, the 

Secretary will make BPI gathered in the 

final phase of these investigations 

available to authorized applicants under 

the APO issued in the investigations, 

provided that the application is made 

no later than 21 days prior to the 

hearing date specified in this notice. 

Authorized applicants must represent 

interested parties, as defined by 19 

U.S.C. 1677(9), who are parties to the 

investigations. A party granted access to 

BPI in the preliminary phase of the 

investigations need not reapply for such 

access. A separate service list will be 

maintained by the Secretary for those 

parties authorized to receive BPI under 

the APO. 

Staff report.—The prehearing staff 

report in the final phase of these 

investigations will be placed in the 

nonpublic record on March 4, 2021, and 

a public version will be issued 

thereafter, pursuant to § 207.22 of the 

Commission’s rules. 

Hearing.— The Commission will hold 

a hearing in connection with the final 

phase of these investigations beginning 

at 9:30 a.m. on Thursday, March 18, 

2021. Information about the place and 

form of the hearing, including about 

how to participate in and/or view the 

hearing, will be posted on the 

Commission’s website at https:// 

www.usitc.gov/calendarpad/ 

calendar.html. Interested parties should 

check the Commission’s website 

periodically for updates. Requests to 

appear at the hearing should be filed in 

writing with the Secretary to the 

Commission on or before Friday, March 

12, 2021. A nonparty who has testimony 

that may aid the Commission’s 

deliberations may request permission to 

present a short statement at the hearing. 

All parties and nonparties desiring to 

appear at the hearing and make oral 

presentations should attend a 

prehearing conference to be held at 9:30 

a.m. on Tuesday, March 16, 2021. Oral 

testimony and written materials to be 

submitted at the public hearing are 

governed by sections 201.6(b)(2), 

201.13(f), and 207.24 of the 

Commission’s rules. Parties must submit 

any request to present a portion of their 

hearing testimony in camera no later 

than 7 business days prior to the date of 

the hearing. 

Written submissions.—Each party 

who is an interested party shall submit 

a prehearing brief to the Commission. 

Prehearing briefs must conform with the 

provisions of § 207.23 of the 

Commission’s rules; the deadline for 

filing is March 11, 2021. Parties may 

also file written testimony in connection 

with their presentation at the hearing, as 

provided in § 207.24 of the 

Commission’s rules, and posthearing 

briefs, which must conform with the 

provisions of § 207.25 of the 

Commission’s rules. The deadline for 

filing posthearing briefs is March 25, 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 85, No. 229 / Friday, November 27, 2020 / Notices 76107 

2021. In addition, any person who has 

not entered an appearance as a party to 

the investigations may submit a written 

statement of information pertinent to 

the subject of the investigations, 

including statements of support or 

opposition to the petition, on or before 

March 25, 2021. On April 14, 2021, the 

Commission will make available to 

parties all information on which they 

have not had an opportunity to 

comment. Parties may submit final 

comments on this information on or 

before April 16, 2021, but such final 

comments must not contain new factual 

information and must otherwise comply 

with § 207.30 of the Commission’s rules. 

All written submissions must conform 

with the provisions of § 201.8 of the 

Commission’s rules; any submissions 

that contain BPI must also conform with 

the requirements of §§ 201.6, 207.3, and 

207.7 of the Commission’s rules. The 

Commission’s Handbook on Filing 

Procedures, available on the 

Commission’s website at https:// 

www.usitc.gov/documents/handbook_

on_filing_procedures.pdf, elaborates 

upon the Commission’s procedures with 

respect to filings. 

Additional written submissions to the 

Commission, including requests 

pursuant to § 201.12 of the 

Commission’s rules, shall not be 

accepted unless good cause is shown for 

accepting such submissions, or unless 

the submission is pursuant to a specific 

request by a Commissioner or 

Commission staff. 

In accordance with §§ 201.16(c) and 

207.3 of the Commission’s rules, each 

document filed by a party to the 

investigations must be served on all 

other parties to the investigations (as 

identified by either the public or BPI 

service list), and a certificate of service 

must be timely filed. The Secretary will 

not accept a document for filing without 

a certificate of service. 

Authority: These investigations are being 

conducted under authority of title VII of the 

Tariff Act of 1930; this notice is published 

pursuant to § 207.21 of the Commission’s 

rules. 

By order of the Commission. 

Issued: November 20, 2020. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2020–26164 Filed 11–25–20; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF JUSTICE 

Antitrust Division 

Notice Pursuant to the National 

Cooperative Research and Production 

Act of 1993—Open Source Imaging 

Consortium, Inc. 

Notice is hereby given that, on 

November 13, 2020, pursuant to Section 

6(a) of the National Cooperative 

Research and Production Act of 1993, 

15 U.S.C. 4301 et seq. (‘‘the Act’’), Open 

Source Imaging Consortium, Inc. 

(‘‘Open Source Imaging Consortium’’) 

has filed written notifications 

simultaneously with the Attorney 

General and the Federal Trade 

Commission disclosing changes in its 

membership. The notifications were 

filed for the purpose of extending the 

Act’s provisions limiting the recovery of 

antitrust plaintiffs to actual damages 

under specified circumstances. 

Specifically, Vida Diagnostics, Inc., 

Coralville, IA; and University of Genoa, 

Genoa, ITALY, have been added as 

parties to this venture. 

No other changes have been made in 

either the membership or planned 

activity of the group research project. 

Membership in this group research 

project remains open, and Open Source 

Imaging Consortium intends to file 

additional written notifications 

disclosing all changes in membership. 

On March 20, 2019, Open Source 

Imaging Consortium filed its original 

notification pursuant to Section 6(a) of 

the Act. The Department of Justice 

published a notice in the Federal 

Register pursuant to Section 6(b) of the 

Act on April 12, 2019 (84 FR 14973). 

The last notification was filed with 

the Department on August 19, 2020. A 

notice was published in the Federal 

Register pursuant to Section 6(b) of the 

Act on August 28, 2020 (85 FR 53402). 

Suzanne Morris, 

Chief, Premerger and Division Statistics, 

Antitrust Division. 

[FR Doc. 2020–26188 Filed 11–25–20; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–744] 

Importer of Controlled Substances 

Application: Meridian Medical 

Technologies 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Meridian Medical 

Technologies has applied to be 

registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to Supplemental Information 

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before December 28, 2020. Such 

persons may also file a written request 

for a hearing on the application on or 

before December 28, 2020. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for a 

hearing should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on November 3, 2020, 

Meridian Medical Technologies, 2555 

Hermelin Drive, Saint Louis, Missouri 

63144, applied to be registered as an 

importer of the following basic class(es) 

of controlled substance(s): 

Controlled substance Drug code Schedule 

Morphine .................................................................................................................................................................. 9300 II 

The company manufactures a product 

containing morphine in the United 

States. The company exports this 

product to customers around the world. 

The company has been asked to ensure 

that its product, which is sold to 


jbell on DSKJLSW7X2PROD with NOTICES